Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms

Detalles Bibliográficos
Autores principales: Anasiewicz, Natalie, Seeli, Corsin, Brüggen, Marie-Charlotte, Möhrenschlager, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891745/
https://www.ncbi.nlm.nih.gov/pubmed/36748045
http://dx.doi.org/10.1007/s40629-023-00245-w
_version_ 1784881196018171904
author Anasiewicz, Natalie
Seeli, Corsin
Brüggen, Marie-Charlotte
Möhrenschlager, Matthias
author_facet Anasiewicz, Natalie
Seeli, Corsin
Brüggen, Marie-Charlotte
Möhrenschlager, Matthias
author_sort Anasiewicz, Natalie
collection PubMed
description
format Online
Article
Text
id pubmed-9891745
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-98917452023-02-02 Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms Anasiewicz, Natalie Seeli, Corsin Brüggen, Marie-Charlotte Möhrenschlager, Matthias Allergo J Int Case Report Springer Medizin 2023-02-01 /pmc/articles/PMC9891745/ /pubmed/36748045 http://dx.doi.org/10.1007/s40629-023-00245-w Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Anasiewicz, Natalie
Seeli, Corsin
Brüggen, Marie-Charlotte
Möhrenschlager, Matthias
Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title_full Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title_fullStr Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title_full_unstemmed Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title_short Coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate COVID-19 symptoms
title_sort coronavirus infection in an unvaccinated atopic dermatitis patient under ongoing dupilumab therapy: eczema flare-up, but moderate covid-19 symptoms
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891745/
https://www.ncbi.nlm.nih.gov/pubmed/36748045
http://dx.doi.org/10.1007/s40629-023-00245-w
work_keys_str_mv AT anasiewicznatalie coronavirusinfectioninanunvaccinatedatopicdermatitispatientunderongoingdupilumabtherapyeczemaflareupbutmoderatecovid19symptoms
AT seelicorsin coronavirusinfectioninanunvaccinatedatopicdermatitispatientunderongoingdupilumabtherapyeczemaflareupbutmoderatecovid19symptoms
AT bruggenmariecharlotte coronavirusinfectioninanunvaccinatedatopicdermatitispatientunderongoingdupilumabtherapyeczemaflareupbutmoderatecovid19symptoms
AT mohrenschlagermatthias coronavirusinfectioninanunvaccinatedatopicdermatitispatientunderongoingdupilumabtherapyeczemaflareupbutmoderatecovid19symptoms

Ejemplares similares